Brief: Cassava Sciences Says Engaging With DOJ And SEC Regarding Ongoing Investigations Into Co & Two Senior Employees

Filana Therapeutics

01/07/2024 14:44

July 1 (Reuters) - Cassava Sciences Inc  SAVA.O :
    * CASSAVA SCIENCES : ENGAGING WITH DOJ AND SEC IN CONNECTION
WITH
ONGOING INVESTIGATIONS INTO CO AND TWO SENIOR EMPLOYEES
    * CASSAVA SCIENCES INC -BOARD  EMPOWERED AD HOC
INVESTIGATION
COMMITTEE TO DIRECT AN INVESTIGATION OF THE INFORMATION PROVIDED
BY THE SEC
    * CASSAVA SCIENCES INC: INTERNAL INVESTIGATION ALSO
EVALUATING
INFORMATION CONTAINED IN DOJ INDICTMENT OF HOAU-YAN WANG
    * CASSAVA SCIENCES INC: BASED ON COMMITTEE REVIEW OF
INTERNAL
INVESTIGATION TO DATE, SUPPLEMENTING ITS PRIOR DISCLOSURES
REGARDING PHASE 2B STUDY
    * CASSAVA SCIENCES: CONDUCTING TWO RANDOMIZED,
PLACEBO-CONTROLLED
PHASE 3 CLINICAL TRIALS ORAL SIMUFILAM IN PATIENTS WITH
MILD-TO-MODERATE ALZHEIMER’S
    * CASSAVA SCIENCES: INTERNAL INVESTIGATION DETERMINED SOME
INFORMATION COULD HAVE BEEN USED TO UNBLIND WANG TO SOME PHASE
2B STUDY PARTICIPANTS

Source text for Eikon:  ID:n0001493152-24-025725 
Further company coverage:  SAVA.O